HROW:NASDAQ
Harrow Inc
30,62 US$
arrow_upward
+0,89%(+0,27) 1D
30,55 US$
arrow_downward
-0,23% (-0,070)todayPara orarit të tregut
Mbyllur: 7 tet, 4:00:01 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për HROW...
Hap
30,09 US$
I lartë
31,11 US$
I ulët
29,90 US$
Kapitalizimi i tregut
1,15 mld
Vëllimi mesatar
542,32 mijë
Vëllimi
854,00
Maksimumi 52-javor
54,85 US$
Minimumi 52-javor
28,54 US$
Fitimet për aksion
-1,00 US$
Beta
0,19
Aksionet në qarkullim
37,49 mln
Numri i punonjësve
373
Hap
30,09 US$
I lartë
31,11 US$
I ulët
29,90 US$
Kapitalizimi i tregut
1,15 mld
Vëllimi mesatar
542,32 mijë
Vëllimi
854,00
Maksimumi 52-javor
54,85 US$
Minimumi 52-javor
28,54 US$
Fitimet për aksion
-1,00 US$
Beta
0,19
Aksionet në qarkullim
37,49 mln
Numri i punonjësve
373
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo Finance Singapore
·
10 orë më parë
Is Harrow (HROW) Undervalued On Growing Conference Buzz Around Its Ophthalmic Pipeline?
Simply Wall Street
·
11 orë më parë
Is Harrow (HROW) Cheap After New Eye Drug Data Took Center Stage?
The Business Journals
·
2 ditë më parë
Harrow invests $30 million in new pharmaceutical as it builds portfolio
TipRanks
·
2 ditë më parë
Harrow Closes TYRVAYA Acquisition, Expanding Dry Eye Portfolio
Profili
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.
In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its chief innovation officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary. Wikipedia
Rreth Harrow Inc
Drejtori ekzekutivMark L. Baum Esq.
Punonjësit373
Themeluar më2012
SeliaNashville, Tennessee, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtiharrow.com